Background: Aerosolized medications are frequently administered across the health care continuum to acutely ill patients. During viral pandemics, the World Health Organization and the Centers for Disease Control and Prevention advise the application of airborne precautions when performing aerosol-generating medical procedures, such as aerosolized medications.
Observations: Appropriate personal protective equipment (PPE), including fit-tested particulate respirators should be worn when administering nebulized medications to patients. These PPEs have been in short supply in the US during early phases of the COVID-19 pandemic, which is increasing the risk faced by health care workers (HCWs) who are treating patients using aerosolized medications. Despite taking appropriate precautions, HCWs are becoming infected with COVID-19. This may be related to secondary exposure related to viral longevity in fugitive emissions and viability on fomites.
Conclusions: We have expanded on non-US public health recommendations to provide guidance to frontline HCWs to enhance collaboration between clinicians, who are often siloed in their clinical practices, and ultimately to protect the federal workforce, which cannot sustain a significant loss of frontline HCWs.
Copyright © 2020 Frontline Medical Communications Inc., Parsippany, NJ, USA.
Conflict of interest statement
Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.
High-Risk Aerosol-Generating Procedures in COVID-19: Respiratory Protective Equipment Considerations.Otolaryngol Head Neck Surg. 2020 May 12:194599820927335. doi: 10.1177/0194599820927335. Online ahead of print. Otolaryngol Head Neck Surg. 2020. PMID: 32396451
Procedural precautions and personal protective equipment during head and neck instrumentation in the COVID-19 era.Head Neck. 2020 Apr 29. doi: 10.1002/hed.26220. Online ahead of print. Head Neck. 2020. PMID: 32348594
Personal protective equipment (PPE) for both anesthesiologists and other airway managers: principles and practice during the COVID-19 pandemic.Can J Anaesth. 2020 Apr 23:1-11. doi: 10.1007/s12630-020-01673-w. Online ahead of print. Can J Anaesth. 2020. PMID: 32329014 Free PMC article.
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.Cochrane Database Syst Rev. 2016 Apr 19;4:CD011621. doi: 10.1002/14651858.CD011621.pub2. Cochrane Database Syst Rev. 2016. PMID: 27093058 Updated. Review.
Respiratory Precautions for Protection from Bioaerosols or Infectious Agents: A Review of the Clinical Effectiveness and Guidelines [Internet].Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Aug 19. Canadian Agency for Drugs and Technologies in Health. 2014. PMID: 25411668 Free Books & Documents. Review.